ADRX, Inc.
Biotechnology company · Thousand Oaks, California, United States
ADRX, Inc. is a biotechnology company headquartered in Thousand Oaks, California, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2020.
ADRX at a glance
What does ADRX do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $1 million in total (2022). NIH funding came from the National Institute of General Medical Sciences, National Institute on Aging, National Center for Advancing Translational Sciences.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $6 million sold (2020).
Frequently asked questions about ADRX
Where is ADRX headquartered?
ADRX, Inc. is headquartered in Thousand Oaks, California, United States.
What does ADRX do?
ADRX, Inc. is a biotechnology company.
Similar companies
- Amgen IncThousand Oaks, California, United States
- Atara Biotherapeutics, Inc.Thousand Oaks, California, United States
- LungLife AI, Inc.Thousand Oaks, California, United States
- Suvalent Therapeutics Inc.Thousand Oaks, California, United States
- Proactive Diagnostics, Inc.Thousand Oaks, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences